Cargando…
Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma
Melanoma tumors usually retain wild-type p53; however, its tumor-suppressor activity is functionally disabled, most commonly through an inactivating interaction with mouse double-minute 2 homolog (Mdm2), indicating p53 release from this complex as a potential therapeutic approach. P53 and the tumor-...
Autores principales: | Worrall, C, Suleymanova, N, Crudden, C, Trocoli Drakensjö, I, Candrea, E, Nedelcu, D, Takahashi, S-I, Girnita, L, Girnita, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474566/ https://www.ncbi.nlm.nih.gov/pubmed/28092675 http://dx.doi.org/10.1038/onc.2016.472 |
Ejemplares similares
-
Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation
por: Suleymanova, Naida, et al.
Publicado: (2017) -
Functional antagonism of β-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes
por: Suleymanova, N, et al.
Publicado: (2017) -
Targeting the IGF-1R: The Tale of the Tortoise and the Hare
por: Crudden, Caitrin, et al.
Publicado: (2015) -
Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey
por: Crudden, Caitrin, et al.
Publicado: (2019) -
Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment
por: Helgadottir, Hildur, et al.
Publicado: (2018)